Hydrogen Bromide → Vortioxetine hydrobromide

HRID 1909084ノート

反応式

HRID 1909084 の反応式
[CH3:1][C:2]1[CH:7]=[C:6]([CH3:8])[CH:5]=[CH:4][C:3]=1[S:9][C:10]1[CH:15]=[CH:14][CH:13]=[CH:12][C:11]=1[N:16]1[CH2:21][CH2:20][NH:19][CH2:18][CH2:17]1.[BrH:22]>C(OCC)(=O)C>[BrH:22].[CH3:1][C:2]1[CH:7]=[C:6]([CH3:8])[CH:5]=[CH:4][C:3]=1[S:9][C:10]1[CH:15]=[CH:14][CH:13]=[CH:12][C:11]=1[N:16]1[CH2:17][CH2:18][NH:19][CH2:20][CH2:21]1

参加物

4

反応物 2

HCID 260Hydrogen BromideHCID 9966051Vortioxetine

生成物 1

HCID 56843850Vortioxetine hydrobromide収率 47%

試薬・触媒・溶媒 1

HCID 8857Ethyl Acetate溶媒

実験手順

49.5 gram of 1-[2-(2,4-Dimethylphenylsulfanyl)-phenyl]piperazine colourless oil was dissolved in 500 mL ethyl acetate and added 18.5 mL 48%-wt HBr (aq). This addition caused formation of a thick slurry which was stirred over night at room temperature. Filtration and drying in vacuum (50° C.) over night produced the product in 29.6 gram as white solid (47%).

後処理

  1. additionThis addition
  2. filtrationFiltration
  3. customdrying in vacuum (50° C.) over night

出典と根拠

ORDレコード
ord-9e2ee4c50fe342778d20e638180395d5
出典データセット
uspto-grants-2013_12
特許番号
US08598348B2

反応ノート

読み込み中…